智利危重症 COVID-19 相关霉菌感染
COVID-19-Associated Mold Infection in Critically Ill Patients, Chile.
出版信息
Emerg Infect Dis. 2021 May;27(5):1454-1456. doi: 10.3201/eid2705.204412. Epub 2021 Mar 24.
Abstract
Patients with severe coronavirus disease (COVID-19) may have COVID-19-associated invasive mold infection (CAIMI) develop. We report 16 cases of CAIMI among 146 nonimmunocompromised patients with severe COVID-19 at an academic hospital in Santiago, Chile. These rates correspond to a CAIMI incidence of 11%; the mortality rate for these patients was 31.2%.
摘要
患有严重冠状病毒病 (COVID-19) 的患者可能会发生 COVID-19 相关侵袭性霉菌感染 (CAIMI)。我们报告了智利圣地亚哥一家学术医院的 146 例严重 COVID-19 非免疫功能低下患者中 16 例 CAIMI。这些比率相当于 11%的 CAIMI 发病率；这些患者的死亡率为 31.2%。
相似文献
1
COVID-19-Associated Mold Infection in Critically Ill Patients, Chile.智利危重症 COVID-19 相关霉菌感染
Emerg Infect Dis. 2021 May;27(5):1454-1456. doi: 10.3201/eid2705.204412. Epub 2021 Mar 24.
2
Multisystem Inflammatory Syndrome in Children, Chile, May-August 2020.2020年5月至8月，智利儿童多系统炎症综合征
Emerg Infect Dis. 2021 May;27(5):1457-1461. doi: 10.3201/eid2705.204591. Epub 2021 Mar 24.
3
Comparison of the First and Second Wave of Infections by SARS-CoV-2: A Retrospective and Longitudinal Study From a Primary Health Care Center in Santiago of Chile.比较 SARS-CoV-2 的第一波和第二波感染：智利圣地亚哥的一个初级保健中心的回顾性和纵向研究。
Front Public Health. 2022 Jun 30;10:913519. doi: 10.3389/fpubh.2022.913519. eCollection 2022.
4
Severe Acute Respiratory Syndrome Coronavirus 2 Pandemic: Chilean Air Force Experience in the Air Transport of Critically Ill Patients-The First 100 Cases.严重急性呼吸综合征冠状病毒 2 型大流行：智利空军在危重症患者空运中的经验——前 100 例。
Air Med J. 2022 Jul-Aug;41(4):396-401. doi: 10.1016/j.amj.2021.12.007. Epub 2022 Jan 10.
5
A survey on acute kidney injury in severely and critically ill COVID-19 patients without chronic kidney disease.一项关于无慢性肾脏病的重症 COVID-19 患者急性肾损伤的调查。
Ann Palliat Med. 2021 Jun;10(6):6198-6207. doi: 10.21037/apm-20-2170. Epub 2021 May 17.
6
Risks and features of secondary infections in severe and critical ill COVID-19 patients.COVID-19 重症和危重症患者继发感染的风险和特征。
Emerg Microbes Infect. 2020 Dec;9(1):1958-1964. doi: 10.1080/22221751.2020.1812437.
7
[Challenges in the management of analgesia and sedation in critically ill patients with COVID-19 in Chile].[智利新冠肺炎危重症患者镇痛与镇静管理面临的挑战]
Rev Med Chil. 2021 Apr;149(4):559-569. doi: 10.4067/s0034-98872021000400559.
8
Human and novel coronavirus infections in children: a review.儿童人感染和新型冠状病毒感染：综述。
Paediatr Int Child Health. 2021 Feb;41(1):36-55. doi: 10.1080/20469047.2020.1781356. Epub 2020 Jun 25.
9
Fatal Invasive Aspergillosis and Coronavirus Disease in an Immunocompetent Patient.免疫功能正常患者的侵袭性曲霉病和冠状病毒病致死。
Emerg Infect Dis. 2020 Jul;26(7):1636-1637. doi: 10.3201/eid2607.201603. Epub 2020 Jun 21.
10
Bioaerosol Sampling for Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in a Referral Center with Critically Ill Coronavirus Disease 2019 (COVID-19) Patients March-May 2020.2020 年 3 月至 5 月，在一家收治危重新冠肺炎（COVID-19）患者的转诊中心，对严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）进行生物气溶胶采样。
Clin Infect Dis. 2021 Oct 5;73(7):e1790-e1794. doi: 10.1093/cid/ciaa1880.
引用本文的文献
1
Risk factors for invasive mold infection after COVID-19: case-control study.新冠病毒感染后侵袭性霉菌感染的危险因素：病例对照研究
Afr Health Sci. 2024 Dec;24(4):77-84. doi: 10.4314/ahs.v24i4.10.
2
Mixed Aspergillosis and Mucormycosis Infections in Patients with COVID-19: Case Series and Literature Review.COVID-19 患者混合曲霉病和毛霉菌病感染：病例系列和文献复习。
Mycopathologia. 2024 Jan 17;189(1):10. doi: 10.1007/s11046-023-00808-z.
3
Clinicoradiological Profile of COVID-19-Associated Rhino-Orbital Cerebral Mucormycosis with a Focus on Computed Tomography: A Clinical Case Series and Review.COVID-19 相关的 Rhino-Orbital Cerebral Mucormycosis 的临床放射学特征：一项临床病例系列研究和综述。
Am J Trop Med Hyg. 2023 Jul 24;109(3):600-607. doi: 10.4269/ajtmh.22-0298. Print 2023 Sep 6.
4
COVID-19, mucormycosis, and the cow: Damned lies!新型冠状病毒肺炎、毛霉菌病与牛：可恶的谎言！
Indian J Med Microbiol. 2023 Jul-Aug;44:100382. doi: 10.1016/j.ijmmb.2023.100382. Epub 2023 May 24.
5
Metatranscriptomic analysis revealed as a potential biomarker of oropharyngeal microbiomes in SARS-CoV-2 infection.宏转录组分析显示 可能是 SARS-CoV-2 感染口咽微生物组的生物标志物。
Front Cell Infect Microbiol. 2023 Jun 2;13:1161763. doi: 10.3389/fcimb.2023.1161763. eCollection 2023.
6
Clinical and mycological investigations of post-COVID-19 acute invasive fungal sinusitis.新冠后急性侵袭性真菌性鼻窦炎的临床与真菌学研究
Laryngoscope Investig Otolaryngol. 2022 Oct 28;7(6):1780-1789. doi: 10.1002/lio2.956. eCollection 2022 Dec.
7
Is the production of reactive oxygen and nitrogen species by macrophages associated with better infectious control in female mice with experimentally disseminated and pulmonary mucormycosis?巨噬细胞产生的活性氧和氮物种是否与实验性播散性和肺毛霉菌病的雌性小鼠中更好的感染控制有关？
PLoS One. 2022 Dec 15;17(12):e0270071. doi: 10.1371/journal.pone.0270071. eCollection 2022.
8
Secondary respiratory early and late infections in mechanically ventilated patients with COVID-19.COVID-19 机械通气患者的继发呼吸道早晚期感染。
BMC Infect Dis. 2022 Sep 29;22(1):760. doi: 10.1186/s12879-022-07743-2.
9
The Menace of Epidemic Amidst the COVID-19 Pandemic: A Systematic Review.新冠疫情期间流行病的威胁：一项系统综述
Diseases. 2022 Aug 29;10(3):58. doi: 10.3390/diseases10030058.
10
The role of SARS-CoV-2 immunosuppression and the therapy used to manage COVID-19 disease in the emergence of opportunistic fungal infections: A review.严重急性呼吸综合征冠状病毒2型（SARS-CoV-2）免疫抑制及用于治疗2019冠状病毒病（COVID-19）的疗法在机会性真菌感染发生中的作用：综述
Curr Res Biotechnol. 2022;4:337-349. doi: 10.1016/j.crbiot.2022.08.001. Epub 2022 Aug 3.
本文引用的文献
1
[Epidemiology of invasive fungal disease by filamentous fungi in the period 2005 to 2015, in a university hospital in Santiago, Chile].[2005年至2015年期间，智利圣地亚哥一家大学医院丝状真菌引起的侵袭性真菌病流行病学]
Rev Chilena Infectol. 2019 Dec;36(6):732-741. doi: 10.4067/S0716-10182019000600732.
2
Coronavirus Disease (Covid-19) Associated Mucormycosis (CAM): Case Report and Systematic Review of Literature.冠状病毒病（新冠-19）相关毛霉菌病（CAM）：病例报告及文献系统综述
Mycopathologia. 2021 May;186(2):289-298. doi: 10.1007/s11046-021-00528-2. Epub 2021 Feb 5.
3
Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance.定义和管理新型冠状病毒肺炎相关肺曲霉病：2020年欧洲临床微生物与感染性疾病学会/国际人类与动物真菌学会研究和临床指南共识标准
Lancet Infect Dis. 2021 Jun;21(6):e149-e162. doi: 10.1016/S1473-3099(20)30847-1. Epub 2020 Dec 14.
4
Aspergillosis Complicating Severe Coronavirus Disease.曲霉病合并严重冠状病毒病。
Emerg Infect Dis. 2021 Jan;27(1):18-25. doi: 10.3201/eid2701.202896. Epub 2020 Oct 21.
5
Epidemiology of Invasive Pulmonary Aspergillosis Among Intubated Patients With COVID-19: A Prospective Study.COVID-19 气管插管患者侵袭性肺曲霉病的流行病学：一项前瞻性研究。
Clin Infect Dis. 2021 Dec 6;73(11):e3606-e3614. doi: 10.1093/cid/ciaa1065.
6
Invasive pulmonary fusariosis in an immunocompetent critically ill patient with severe COVID-19.一名患有严重新型冠状病毒肺炎（COVID-19）的免疫功能正常的重症患者发生侵袭性肺镰刀菌病。
Clin Microbiol Infect. 2020 Nov;26(11):1582-1584. doi: 10.1016/j.cmi.2020.06.026. Epub 2020 Jun 30.
7
Bacterial and fungal coinfection among hospitalized patients with COVID-19: a retrospective cohort study in a UK secondary-care setting.COVID-19 住院患者的细菌和真菌感染：英国二级保健机构中的回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1395-1399. doi: 10.1016/j.cmi.2020.06.025. Epub 2020 Jun 27.
8
Clinical characteristics of invasive pulmonary aspergillosis in patients with COVID-19 in Zhejiang, China: a retrospective case series.中国浙江新冠肺炎患者侵袭性肺曲霉病的临床特征：一项回顾性病例系列研究
Crit Care. 2020 Jun 5;24(1):299. doi: 10.1186/s13054-020-03046-7.
9
COVID-19-associated invasive pulmonary aspergillosis.新型冠状病毒肺炎相关侵袭性肺曲霉病
Ann Intensive Care. 2020 Jun 1;10(1):71. doi: 10.1186/s13613-020-00686-4.
10
Prevalence of putative invasive pulmonary aspergillosis in critically ill patients with COVID-19.新型冠状病毒肺炎（COVID-19）重症患者中疑似侵袭性肺曲霉病的患病率。
Lancet Respir Med. 2020 Jun;8(6):e48-e49. doi: 10.1016/S2213-2600(20)30237-X. Epub 2020 May 20.
Zotero 插件